Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
← Research & Industry News
External source

Gene editing could replace a lifetime of medication, but there's a catch

A single gene-editing treatment could someday protect against heart disease, high cholesterol, and other common conditions for decades, potentially replacing lifelong medications. But scientists warn that permanently altering genes introduces risks that could take years to emerge, making long-term safety a critical challenge.

Published by
ScienceDaily
Evidence type
Laboratory

A single gene-editing treatment could someday protect against heart disease, high cholesterol, and other common conditions for decades, potentially replacing lifelong medications. But scientists warn that permanently altering genes introduces risks that could take years to emerge, making long-term safety a critical challenge.

This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at ScienceDaily.

Drug Delivery & Nanomedicine

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.
Gene editing could replace a lifetime of medication, but there's a catch | Brilliant Blue Biosciences